This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use



The business of precision medicine – visioning the Future

Location: Horizon, 2 Brewery Wharf, Leeds, LS10 1JR

This inaugural Bionow Precision Medicine Conference, co-hosted by the Northern Health Science Alliance, will focus on the impact which this exciting area has on patients and given the strengths in the North, will also examine precision medicine as a key tool in reducing the North / South economic differential.

Participants will consider how key developments in the area can become an economic reality to deliver new standards of care for patients, also how and when P4 Medicine might come to fruition.

We are delighted to have keynote presentations from Prof Sue Hill, Chief Scientific Officer at NHS England and the conference sponsor QIAGEN.

The event will feature sessions looking in depth at Precision Medicine in the key areas of inflammatory disease, cancer, cardiovascular / metabolic, infection, health economics and clinical trials. Drawing upon experts from the academic, clinical and industry arenas the event will appeal to experts in the field as well as those looking to broaden their understanding of the business-related opportunities of bringing new products to patients.

Precision Medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work best in specific groups of people. P4 Medicine will further revolutionise medicine and build upon the opportunity to deliver care which is Predictive, Preventive, Personalized and Participatory.

Conference Programme


Session Title 


Parallel Sessions





Welcome Address 

Dr John Stageman,

Chair, Bionow



Prof Sue Hill,

Chief Scientific Officer, NHS England


Inflammatory Disease

Chris Griffiths, Professor of Dermatology, University of Manchester

David Jones, Professor of Liver Immunology, Newcastle University

Ian Bruce, Chair in Rheumatology, University of Manchester

Cardiovascular / Metabolic

Alistair Hall, Professor of Clinical Cardiology, University of Leeds

Azfar Zaman, Hon Clin Prof of Cardiology, Newcastle University

Guillaume Saint-Pierre, CEO, PeptiGelDesign


Coffee, Networking,


The Science of What's Possible

Kendon Graham, Informatics Product Owner, Waters Corporation


Stratified Clinical Trials

Jonathan Sheffield, CEO, NIHR CRN

Emma Banks, CEO, Datatrial


Patients Perspective

Alistair Kent, Director, Genetic Alliance


Lunch, Networking,


Industry Keynote

Jonathan Perkins, Senior Manager, QIAGEN 



Darren Hodgson, Senior Principal Scientist, AstraZeneca

Ansar Jawaid, CEO, Precision Medicine

Gareth Evans, Professor in Med Genetics & Cancer Epi, University of Manchester

Infection and Adverse effects of drugs

Neil French, Senior Scientific Operations Manager, MRC Centre for Drug Safety Science

Enitan Carrol, Professor of Paediatric, Infection, University of Liverpool

Peter Maguire, CEO, MC Diagnostics


Health Economics

Matthew Taylor, Director, YHEC

Katherine Payne, Professor of Health Economics, University of Manchester


The future - Reducing Precision Medicine to practice, how do we make it a reality for patients?

Hakim Yadi, CEO, NHSA

Joanne Hackett, Investor

Nevile Young, Programme Manager, AHSN

Rebecca Lumsden, Head of Science Policy, ABPI



Delegate Prices
Premium Member: £115.00 + VAT
Member: £145.00 + VAT
Non-member: £199.00 + VAT

For details of the sponsorship opportunities available at the conference please contact Helen Williams on 07714 168020 or at

> Register here